Cargando…
Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911998/ https://www.ncbi.nlm.nih.gov/pubmed/35271561 http://dx.doi.org/10.15585/mmwr.mm7110a1 |
| _version_ | 1784666989497679872 |
|---|---|
| author | Chung, Jessie R. Kim, Sara S. Kondor, Rebecca J. Smith, Catherine Budd, Alicia P. Tartof, Sara Y. Florea, Ana Talbot, H. Keipp Grijalva, Carlos G. Wernli, Karen J. Phillips, C. Hallie Monto, Arnold S. Martin, Emily T. Belongia, Edward A. McLean, Huong Q. Gaglani, Manjusha Reis, Michael Geffel, Krissy Moehling Nowalk, Mary Patricia DaSilva, Juliana Keong, Lisa M. Stark, Thomas J. Barnes, John R. Wentworth, David E. Brammer, Lynnette Burns, Erin Fry, Alicia M. Patel, Manish M. Flannery, Brendan |
| author_facet | Chung, Jessie R. Kim, Sara S. Kondor, Rebecca J. Smith, Catherine Budd, Alicia P. Tartof, Sara Y. Florea, Ana Talbot, H. Keipp Grijalva, Carlos G. Wernli, Karen J. Phillips, C. Hallie Monto, Arnold S. Martin, Emily T. Belongia, Edward A. McLean, Huong Q. Gaglani, Manjusha Reis, Michael Geffel, Krissy Moehling Nowalk, Mary Patricia DaSilva, Juliana Keong, Lisa M. Stark, Thomas J. Barnes, John R. Wentworth, David E. Brammer, Lynnette Burns, Erin Fry, Alicia M. Patel, Manish M. Flannery, Brendan |
| author_sort | Chung, Jessie R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8911998 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89119982022-03-18 Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 Chung, Jessie R. Kim, Sara S. Kondor, Rebecca J. Smith, Catherine Budd, Alicia P. Tartof, Sara Y. Florea, Ana Talbot, H. Keipp Grijalva, Carlos G. Wernli, Karen J. Phillips, C. Hallie Monto, Arnold S. Martin, Emily T. Belongia, Edward A. McLean, Huong Q. Gaglani, Manjusha Reis, Michael Geffel, Krissy Moehling Nowalk, Mary Patricia DaSilva, Juliana Keong, Lisa M. Stark, Thomas J. Barnes, John R. Wentworth, David E. Brammer, Lynnette Burns, Erin Fry, Alicia M. Patel, Manish M. Flannery, Brendan MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-03-11 /pmc/articles/PMC8911998/ /pubmed/35271561 http://dx.doi.org/10.15585/mmwr.mm7110a1 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Chung, Jessie R. Kim, Sara S. Kondor, Rebecca J. Smith, Catherine Budd, Alicia P. Tartof, Sara Y. Florea, Ana Talbot, H. Keipp Grijalva, Carlos G. Wernli, Karen J. Phillips, C. Hallie Monto, Arnold S. Martin, Emily T. Belongia, Edward A. McLean, Huong Q. Gaglani, Manjusha Reis, Michael Geffel, Krissy Moehling Nowalk, Mary Patricia DaSilva, Juliana Keong, Lisa M. Stark, Thomas J. Barnes, John R. Wentworth, David E. Brammer, Lynnette Burns, Erin Fry, Alicia M. Patel, Manish M. Flannery, Brendan Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 |
| title | Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 |
| title_full | Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 |
| title_fullStr | Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 |
| title_full_unstemmed | Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 |
| title_short | Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 |
| title_sort | interim estimates of 2021–22 seasonal influenza vaccine effectiveness — united states, february 2022 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911998/ https://www.ncbi.nlm.nih.gov/pubmed/35271561 http://dx.doi.org/10.15585/mmwr.mm7110a1 |
| work_keys_str_mv | AT chungjessier interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT kimsaras interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT kondorrebeccaj interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT smithcatherine interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT buddaliciap interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT tartofsaray interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT floreaana interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT talbothkeipp interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT grijalvacarlosg interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT wernlikarenj interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT phillipschallie interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT montoarnolds interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT martinemilyt interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT belongiaedwarda interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT mcleanhuongq interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT gaglanimanjusha interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT reismichael interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT geffelkrissymoehling interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT nowalkmarypatricia interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT dasilvajuliana interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT keonglisam interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT starkthomasj interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT barnesjohnr interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT wentworthdavide interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT brammerlynnette interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT burnserin interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT fryaliciam interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT patelmanishm interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 AT flannerybrendan interimestimatesof202122seasonalinfluenzavaccineeffectivenessunitedstatesfebruary2022 |